US Stocks
/
NextCure, Inc. Share Price

NextCure, Inc. Share Price

NASDAQ: NXTC | Micro Cap
$5.67
-$0.31 (-5.19%) Last updated on 18 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

NextCure, Inc. Stock Performance

Open
$6.16
Prev. Close
$5.97
Circuit Range
N/A
Day Range
$5.65 - $6.16
Year Range
$1.55 - $15.61
Volume
415
Average Traded
$5.95

NextCure, Inc. Share Price Today

As of 18 September 2026, NextCure, Inc.'s share price is $5.67. The stock opened at $6.16, compared to its previous close of $5.97. During today's trading session, NextCure, Inc.'s share price traded between $5.65 and $6.16, with an average price of $5.91. Over the past 52 weeks, the stock has recorded a high of $15.61 and a low of $1.55. In terms of performance, NextCure, Inc.'s share price has declined by 45.71% over the last six months and is down 3.57% on a year-on-year basis.

NextCure, Inc. Share Price Chart

$5.65$6.16
L
Show Current Price
H

NextCure, Inc. Stock Fundamentals & Key Indicators

Market Cap
$16.10M
PE Ratio (TTM)
-0.29
Dividend Yield
N/A
EPS (TTM)
$-19.65
Revenue (TTM)
N/A
Return On Equity (TTM)
-159.81%
Profit Margin
N/A
Debt to Equity
0.30
Quarterly Earnings Growth YoY
25.27%

NextCure, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$17.11M-$15.40M-$11.54M-$10.98M-$26.81M-$8.62M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A9.95%25.08%4.89%-144.24%67.83%

NextCure, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
Revenue$0.00N/AN/AN/AN/A
Net Profit-$69.39M-$74.73M-$62.72M-$55.65M-$55.84M
Net Profit MarginN/AN/AN/AN/AN/A
Income ChangeN/A-7.70%16.07%11.27%-0.34%

About NextCure, Inc.

NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.

NextCure, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$6.51
$5.65
-7.15%
Aug 2026
$4.32
$6.08
+48.41%
Jul 2026
$1.85
$4.10
+149.24%
Jun 2026
$5.77
$1.65
-73.60%
May 2026
$9.80
$6.23
-33.37%
Apr 2026
$11.28
$9.35
-10.40%
Mar 2026
$12.19
$10.44
-20.95%
Feb 2026
$11.14
$13.20
+20.55%
Jan 2026
$13.43
$10.95
-23.80%
Dec 2025
$12.04
$14.37
+2.35%
Nov 2025
$9.53
$14.04
+11.69%
Oct 2025
$5.72
$12.57
+113.96%

NXTC Share Price FAQs

What is NextCure, Inc. share price today?

chevron-up
NextCure, Inc. share price today is $5.67 as on September 18, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of NextCure, Inc. stock?

chevron-up
The 52 week high of NextCure, Inc. stock is $15.61, while the 52 week low is $1.55 as of 18 Sep '26.

What is NXTC's market capitalisation today?

chevron-up
NXTC market capitalisation is $16.10M as of September 18, 2026, at 2:47 pm IST.

What is NXTC's net income for the last quarter?

chevron-up
NXTC's net income for the last quarter is -0.01B USD.

What is the 5 year returns of NXTC?

chevron-up
The 5 year returns of NXTC is -15.95% as on 18 Sep '26.

What is the high & low stock price of NXTC today?

chevron-up
NXTC stock price hit a high of $6.16 and low of $5.65 as of 18 Sep '26.

Can I buy NXTC shares in India?

chevron-up
Yes. You can buy NXTC in India by opening an international trading account.